POZEN INC POZN (NASDAQ) $ 8.75 Change: +0.54 +6.17% | Volume: 469,500
Sponsored by Click here!

POZEN INC - Fundamental Profile

Company Information

Ticker Symbol: POZN
Exchange: NASD
Contact Info: 1414 Raleigh Road Chapel Hill NC 27517 919 913-1030
CEO/President: John R. Plachetka Ph.D.
Industry: Medical - Drugs / Standard Industry Code: 2834
Description: Pozen Inc. is pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. Its initial area of focus is migraine, where the company have built a portfolio of four product candidates through a combination of innovation and in-licensing. Its lead product candidate is MT 100, which the company is developing as an oral first-line therapy for the treatment of migraine.

Share Information

Shares Outstanding: 29,760 (000) Market Value: 244,360 ($000)
Percentage of Inst.Shareholders: 58.70% Number of Inst.Shareholders: 17.00%
Last Quarter Sales: 33.12 ($Mil.) Last Quarter Net Income: 13.33 ($Mil.)
Last Quarter EPS: 0.43 P/E Ratio: 16
Most Recent Earnings: -0.25 on 05/08/08 Earnings Per Share: 0.52
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

PFIZER INC -40.50 15.14
JOHNSON AND JOH -19.70 55.85
MERCK CO INC -54.70 26.23
BRISTOL MYERS S -39.70 17.56
SCHERING PLOUGH -58.90 13.36